Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis
Stopped Low enrollment/PI relocated. New site couldn't reach agreement with manufacturer
Conditions
- Secondary Progressive Multiple Sclerosis
Interventions
- DRUG: SoluMedrol
- DEVICE: Extracorporeal Photopheresis
Sponsor
University of Utah
Collaborators